In this edition, new cannabinoids hold promise for medical applications; Theranica secures $45 million for migraine treatment device and more.
Read the full coverage here:
Newly discovered cannabinoids hold promise for medical, pain applications
Theranica secures $45 million to expand wearable migraine treatment device in US
Implantable loop recorder screening for AF not linked to stroke reduction risk
Survey shows OTC pain relievers remain ‘common, valuable’
Amneal submits new drug application for extended-release Parkinson’s treatment
References:
Diederichsen SZ et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.3031.
Guglieri M et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.2480.
Jacknin J. How green is my valley: Newly discovered cannabinoids and their possible medical uses. Presented at: PAINWeek; Las Vegas; Sept. 6-9, 2022.
